HIV Surveillance Annual Report, 2023 (PDF)
Annual HIV Surveillance Statistics, 2023 (PDF)
Annual Surveillance Reports
HIV Surveillance Annual Reports:
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005
HIV Surveillance Mid-Year and Quarterly Reports:
Mid-Year 2019 | Mid-Year 2018 | Mid-Year 2017 | Mid-Year 2016 | Mid-Year 2015 | Mid-Year 2014 | Mid-Year 2013 | Mid-Year 2012 | Mid-Year 2011 | Mid-Year 2010 | Mid-Year 2009 | Mid-Year 2008 | Mid-Year 2007 | Mid-Year 2006 | Mid-Year 2005 | First Quarter 2005 | Fourth Quarter 2004 | Third Quarter 2004 | Second Quarter 2004 | First Quarter 2004
Annual Surveillance Statistics
Annual HIV Surveillance Statistics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001
These tables describe new diagnoses of HIV and AIDS, people with HIV and AIDS, and deaths among people with HIV and AIDS, for New York City overall, and by gender, race or ethnicity, age, borough, transmission category, and neighborhood.
Surveillance Slide Sets
Suggested Citation: HIV Epidemiology Program. New York City HIV Surveillance Slide Sets, 2023. New York City Department of Health and Mental Hygiene: New York, NY. December 2024. Accessed [access date] at HIV in NYC: Statistics and Reports.
Glossary
Age:
Age is calculated as age at diagnosis for HIV and AIDS diagnoses; age as of the end of the calendar year for people with HIV; and age at death for deaths.
AIDS diagnosis:
People receive an AIDS diagnosis when their CD4 cell count drops below 200 cells per milliliter of blood, or they are diagnosed with an opportunistic illness.
Clinical status:
Clinical status is determined as of the end of the calendar year or at date of death.
Concurrent HIV and AIDS diagnoses:
An AIDS diagnosis within 31 days of an HIV diagnosis. People concurrently diagnosed with HIV and AIDS are included in the totals of both HIV diagnoses and AIDS diagnoses.
HIV diagnosis:
A diagnosis of HIV is generally based on a positive multi-test algorithm (screening immunoassay, HIV-1/2 differentiation assay, and RNA test) in adults and a positive PCR (polymerase chain reaction) test in infants younger than 18 months. Since June 1, 2000, laboratories and health care providers in New York State have been required to report positive HIV test results even in people without AIDS.
Race or ethnicity:
Black, white, Asian or Pacific Islander, Native American and Multiracial race categories exclude Latino ethnicity. People with the ethnicity Latino are grouped in the Latino race or ethnicity category, regardless of their race classification.
Transmission category:
HIV surveillance captures information about behaviors possibly related to HIV transmission that occurred any time prior to diagnosis.
The primary transmission categories are men who have sex with men (MSM), injection drug use history (IDU), men who have sex with men and inject drugs (MSM-IDU), heterosexual contact, transgender people with sexual contact (TG-SC), and perinatal transmission.
Men who have sex with men includes men with reported sexual contact with another man, and men with a history of a rectal sexually transmitted infection or proctitis and no other definitive transmission category.
The injection drug use category includes people with a history of taking nonprescribed drugs by injection, intravenously, intramuscularly or subcutaneously, excluding men reporting a history of sex with men.
The men reporting a history of sex with men and injection drug use (MSM-IDU) category includes people meeting the definition of both the men who have sex with men and injection drug use categories as described above.
The heterosexual contact category includes people who had heterosexual sex with a person they know to be living with HIV, a person they know to have injected drugs or a person they know to have received blood products. For women only, it also includes history of sex work, multiple sex partners, diagnosis of a sexually transmitted infection, crack or cocaine use, sex with a bisexual man, probable heterosexual transmission as noted in medical chart or sex with a man and no history of injection drug use.
Transgender people with sexual contact includes people identified as transgender at any time by self-report, a medical provider or chart review, or ongoing data collection who have reported sexual contact and no injection drug use history.
Perinatal includes people who were exposed to HIV during gestation, birth or postpartum through breastfeeding to a parent with HIV.
Other includes people who received treatment for hemophilia, people who received a transfusion or transplant, people with other health care-associated transmission, and children with non-perinatal transmission.
Unknown includes people for whom data are not available to classify them in one of the transmission categories described above.
UHF neighborhood:
This corresponds to a geographic area within New York City that is an aggregate of between one and nine ZIP codes but is smaller than a borough. UHF neighborhoods reflect catchment areas for certain health care facilities. See the table and map of UHF neighborhoods and corresponding ZIP codes (PDF).
Data Sources
New York State law requires providers to report new diagnoses of HIV, AIDS, and HIV-related illness, and laboratories to report patients’ positive HIV test results, viral loads, CD4 counts, and nucleotide sequences results. The NYC Department of Health and Mental Hygiene investigates provider and laboratory reports to identify transmission risk and dates of diagnosis, and searches for unreported diagnoses.
For more information, call 311 or email HIVreport@health.nyc.gov.
National Behavior Surveillance
Medical Monitoring Project